Gabapentin-related changes in renal function: Two case reports

Journal of Clinical Psychopharmacology

Volumn 27, Issue 1, 2007, Pages 117-119

  Silvia, Richard J ^a,b,c,d   Spitznas, Andrew L ^c  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b LEMUEL SHATTUCK HOSPITAL   (United States)

^c INSTITUTE OF LIVING   (United States)

^d UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; GABAPENTIN; TRANQUILIZER;

BIPOLAR DISORDER; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; INTERSTITIAL NEPHRITIS; LETTER; MALE; MIDDLE AGED; NEPHROGENIC DIABETES INSIPIDUS;

AMINES; ANTIMANIC AGENTS; BIPOLAR DISORDER; CYCLOHEXANECARBOXYLIC ACIDS; DIABETES INSIPIDUS, NEPHROGENIC; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL;

EID: 33947536540     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: None     Document Type: Letter

References (13)

1. Carta MG, Hardoy MC, Hardoy MJ, et al. The clinical use of gabapentin in bipolar spectrum disorders. J Affect Dis. 2003;75:83-91. (Pubitemid 36645024)
2. Wang PW, Santosa C, Schumacher M, et al. Gabapentin augmentation therapy in bipolar depression. Bipolar Disord. 2002;4:296-301.
3. Letterman L, Markowitz JS. Gabapentin: a review of published experience in the treatment of bipolar disorder and other psychiatric conditions. Pharmacotherapy. 1999;19:565-572. (Pubitemid 29211801)
4. Pande AC, Pollack MH, Crockatt J, et al. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol. 2000;20:467-471. (Pubitemid 30463763)
5. Pande AC, Davidson JR, Jefferson JW, et al. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol. 1999;19:341-348. (Pubitemid 29344848)
6. Frye MA, Ketter TA, Kimbrell TA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol. 2000;20:607-614.
7. Pande AC, Crockatt JG, Janney CA, et al. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Bipolar Disord. 2000;2:249-255.
8. Grunze H, Dittert S, Bungert M, et al. Renal impairment as a possible side effect of gabapentin. Neuropsychobiology. 1998;38:198-199. (Pubitemid 28479457)
9. Gallay B, de Mattos A, Norman D. Reversible acute renal allograft dysfunction due to gabapentin. Transplantation. 2000;70:208-209. (Pubitemid 30490780)
10. Boton R, Gaviria M, Battle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis. 1987;10:329-345. (Pubitemid 17161686)
11. Bucht G, Wahlin A. Renal concentrating capacity in long-term lithium treatment and after withdrawal of lithium. Acta Med Scand. 1980;207:309-314. (Pubitemid 10149007)
12. Bendz H. Kidney function in a selected lithium population: a prospective, controlled, lithium-withdrawal study. Acta Psychiatr Scand. 1985;72:451-463. (Pubitemid 16173563)
13. Bendz H, Sjodin I, Aurell M. Renal function on and off lithium in patients treated with lithium for 15 years or more. A controlled, prospective lithium-withdrawal study. Nephrol Dial Transplant. 1996;11:457-460. (Pubitemid 26093740)